Episcleritis, Scleritis, and Keratitis



Episcleritis, Scleritis, and Keratitis


Theresa Larson

Shilpa Kodati

H. Nida Sen



EPISCLERITIS

Episcleritis is a self-limiting, generally benign inflammation of the episclera.


Etiology and Epidemiology

• Episcleritis occurs most frequently in young to middle-aged women (20 to 40 years old).

• It is more commonly unilateral (50% to 80%).

• The etiology is unknown in most cases, but it is believed to be immune mediated, and can be associated with systemic disease.




Differential Diagnosis

• Scleritis



  • Compared to scleritis, episcleritis has minimal pain, is less commonly associated with systemic disease, and has a more benign, self-limiting course.

• Pinguecula

• Phlyctenule

• Subconjunctival hemorrhage

• Primary conjunctival malignancy or lymphoma

• Anterior uveitis


Diagnostic Evaluation

• Most cases are idiopathic, although approximately one-third of patients are found to have an underlying systemic disease (rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, granulomatosis with polyangiitis (Wegener granulomatosis), or psoriasis).


• A thorough review of systems is indicated and a targeted systemic workup is necessary in recurrent cases.

• Associated ocular conditions include dry eye, ocular rosacea, and atopic keratoconjunctivitis.



Prognosis

• The prognosis is usually very good in isolated cases of episcleritis, although anterior uveitis and corneal involvement can occur concurrently.

• Episodes may reoccur, but only rarely result in lasting sequelae (Figs. 3-1 and 3-2).



REFERENCES

Foster CS, Sainz de la Maza M. Clinical consideration of episcleritis and scleritis. In: The Sclera. New York, NY: Springer-Verlag; 1994:107.

Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469-476.

Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Am J Ophthalmol. 1994;101: 389-396.



SCLERITIS

Shilpa Kodati

Theresa Larson

H. Nida Sen

Scleritis is characterized by inflammation and edema of scleral and episcleral tissue. It is classified anatomically as either anterior (>90% cases) or posterior (Table 3-1).


ANTERIOR SCLERITIS


Etiology and Epidemiology

• Scleritis is most common in middle-aged women (40 to 60 years old) with approximately 70% of overall cases occurring in women and 30% in men.

• Anterior scleritis is further classified into: diffuse, nodular, necrotizing with inflammation, and necrotizing without inflammation (scleromalacia perforans).

• Necrotizing scleritis is the most severe and destructive form of scleritis and the type most often associated with sight-threatening sequelae.

• About 25% to 40% of patients have a history of systemic disease, most commonly rheumatoid arthritis (Table 3-2). The risk of an underlying systemic disease is higher in patients with necrotizing scleritis (˜50% have a systemic disease).

• Bisphosphonates, erlotinib, and procainamide have been reported to be associated with drug-induced scleritis.

• Infectious scleritis is rare and typically occurs after ophthalmic surgery or trauma. Bacteria are the most commonly reported causative microbe.




Differential Diagnosis

• Episcleritis

• Subconjunctival hemorrhage

• Conjunctival mucosa-associated lymphoid tissue lymphoma

• Anterior uveitis or panuveitis

• Acute angle-closure glaucoma

• Keratitis

• Endophthalmitis

• Carotid or dural sinus fistula


Diagnostic Evaluation

• Given that the onset of scleritis can precede the diagnosis of a systemic disease, a thorough history and careful review of systems is needed. The history and review of systems will ultimately guide diagnostic testing, although recurrent cases of scleritis
and all cases of necrotizing scleritis should be worked up.








TABLE 3-1. Scleritis Clinical Subtypes and Their Prevalence






























Anterior scleritis




Diffuse


40%-45%



Nodular


40%


Necrotizing scleritis




With inflammation


10%



Without inflammation (scleromalacia perforans)


1%-5%


Posterior scleritis


1%-5%


Adapted from Nussenblatt RB, Whitcup SM. Uveitis: Fundamentals and Clinical Practice. 4th ed. Philadelphia, PA: Elsevier; 2010.









TABLE 3-2. Systemic Disease Associations

























































































Noninfectious


Infectious


Other


Connective Tissue Disease


Herpes zoster ophthalmicus


Gout



Rheumatoid arthritis


Herpes simplex keratitis


Rosacea



Juvenile rheumatoid arthritis


Acanthamoeba keratitis


Foreign body reaction Drugs (bisphosphonates)



Reiter syndrome


Syphilis



Systemic lupus erythematosus


Lyme disease




Relapsing polychondritis


Bartonellosis




Polymyositis


Tuberculosis




Inflammatory bowel disease


Pseudomonas aeruginosa




Spondyloarthropathy




Vasculitides





Granulomatosis with polyangiitis (Wegener granulomatosis)





Polyarteritis nodosa





Allergic angiitis of Churg-Strauss





Cogan syndrome





Takayasu disease





Adamantiades-Behçet disease





Sarcoidosis






  • Rheumatoid factor, anti-citrullinated cyclic protein, classical antineutrophil cytoplasmic antibody, protoplasmic-staining antineutrophil cytoplasmic antibody (p-ANCA), myeloperoxidase, antinuclear antibody (ANA), and antidouble stranded DNA, may be considered if an underlying rheumatologic disease is suspected.

• Rule out infectious causes with the appropriate tests, including rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL), fluorescent treponemal antibody absorption (FTA-Abs) or syphilis immunoglobulin G (IgG), purified protein derivative (PPD), and/or QuantiFERON-TB Gold. Orbital computed tomography should be considered in atypical cases or cases of suspected orbital inflammatory syndrome.




Prognosis

• The prognosis varies based on the site of inflammation, associated complications, underlying conditions, and response to therapy. Diffuse anterior scleritis has the best prognosis, whereas necrotizing scleritis has the worst prognosis with the highest rates of visual loss and complications.



REFERENCES

Hodson, KL, Galor A, Karp CL, et al. Epidemiology and visual outcomes in patients with infectious scleritis. Cornea. 2013;32:466-472.

Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Ophthalmology. 2000;130:469-476.

Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119:43-50.

Stern MS, Todorich, B, Faia LJ. Ocular pharmacology for scleritis: review of treatment and a practical perspective. J Ocul Pharmacol Ther. 2017;4:240-246.


POSTERIOR SCLERITIS

Posterior scleritis is an inflammation of the sclera that begins posterior to the ora serrata and involves the posterior aspect of the eye.


Etiology and Epidemiology

• Accounts for <10% of scleritis cases; however, it is often underrecognized because of its nonspecific presentation.




Differential Diagnosis

• Choroidal tumors

• Uveal effusion syndrome


• Rhegmatogenous retinal detachment

• Vogt-Koyanagi-Harada syndrome

• Central serous chorioretinopathy

• Optic neuritis

• Masquerade syndromes (lymphoma, metastatic carcinoma, and choroidal melanoma)


Diagnostic Evaluation

• Laboratory evaluation for an underlying systemic disease is warranted based on the results of a thorough history and review of systems.



  • Rule out treatable infectious causes such as syphilis and tuberculosis (RPR or VDRL, FTA-Abs or syphilis IgG, PPD, and QuantiFERON-TB Gold)

• B-scan: This is very helpful to establish the diagnosis. It demonstrates scleral wall thickness >2 mm in either a diffuse or nodular manner. A T-sign (present in approximately 40% of cases of posterior scleritis) represents a sonographically empty space due to edema surrounding Tenon capsule and the optic nerve.

• Fluorescein and indocyanine green angiography can be performed to exclude other causes, such as Vogt-Koyanagi-Harada syndrome and sarcoidosis.






FIGURE 3-3. Scleritis. Diffuse anterior scleritis is characterized by inflammation of the deep scleral and episcleral vessels, which have a dark red/violaceous hue.



Prognosis

• The prognosis depends on the timeliness of treatment and severity of disease. Patients older than 50 years, patients with an associated systemic disease, and those requiring more aggressive treatment have a greater risk of vision loss.



REFERENCES

Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Ophthalmology. 2000;130:469-476.

Lavric A, Gonzalez-Lopez JJ, Majumder PD, et al. Posterior scleritis: analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients. Ocul Immunol Inflamm. 2016;24(1):6-15.

Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119:43-50.






FIGURE 3-4. Scleritis. Diffuse anterior scleritis with inferotemporal thinning. Note the scleral injection and adjacent scleral thinning recognized by the blue color of the underlying choroid.







FIGURE 3-5. Nodular scleritis. Nodular scleritis and peripheral ulcerative keratitis. The immobile nodule is surrounded by scleral injection. There is a focal, peripheral corneal opacity resulting from past episodes of peripheral ulcerative keratitis.






FIGURE 3-6. Necrotizing scleritis. Necrotizing scleritis in a patient with granulomatosis with polyangiitis with one suture remaining from a past scleral biopsy. Note the white, avascular patch of sclera with surrounding temporal thinning.






FIGURE 3-7. Scleromalacia perforans. An elderly woman with poorly treated rheumatoid arthritis that caused painless scleral thinning through which the underlying blue choroid is visible (necrotizing scleritis without inflammation, or scleromalacia perforans). (Courtesy Sunir J. Garg, MD.)






FIGURE 3-8. A patient with posterior scleritis. A. There are horizontal choroidal folds consistent with a mass (in this case, scleral inflammation) behind the globe. B. The fluorescein angiogram showing the choroidal striations. (Courtesy of William Benson, MD.)







FIGURE 3-9. Posterior scleritis. Posterior scleritis causes disruption of the normal choroidal circulation as well as restriction of scleral outflow through the vortex veins. This causes subsequent dysfunction of the retinal pigment epithelium. A. This can result in a serous retinal detachment. Fluorescein angiography demonstrating (B) pinpoint choroidal leakage with (C) pooling of dye in the late frames. D. B-scan ultrasonography demonstrating thickening of the sclera and choroid (arrows) with edema of Tenon capsule behind the globe, which along with the optic nerve, creates the “T-sign.” (Courtesy William Benson, MD and Eliza Hoskins, MD.)

Only gold members can continue reading. Log In or Register to continue

May 5, 2019 | Posted by in OPHTHALMOLOGY | Comments Off on Episcleritis, Scleritis, and Keratitis
Premium Wordpress Themes by UFO Themes